LOC729603 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.561000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.096400E-02
Normal-vs-Stage2
3.019900E-03
Normal-vs-Stage3
5.519400E-03
Normal-vs-Stage4
6.758000E-02
Stage1-vs-Stage2
7.611400E-01
Stage1-vs-Stage3
4.294800E-01
Stage1-vs-Stage4
7.875000E-01
Stage2-vs-Stage3
1.994170E-01
Stage2-vs-Stage4
8.881200E-01
Stage3-vs-Stage4
3.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.580700E-03
Normal-vs-AfricanAmerican
1.930480E-02
Normal-vs-Asian
2.047600E-02
Caucasian-vs-AfricanAmerican
9.280600E-01
Caucasian-vs-Asian
6.360400E-01
AfricanAmerican-vs-Asian
8.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.796500E-03
Normal-vs-Female
7.631200E-04
Male-vs-Female
8.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.211990E-02
Normal-vs-Age(41-60Yrs)
1.031570E-02
Normal-vs-Age(61-80Yrs)
7.628600E-04
Normal-vs-Age(81-100Yrs)
7.360300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.901000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.844800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.109600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.006500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.300200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.688130E-02
Normal-vs-Daily Drinker
4.192900E-04
Normal-vs-Weekly Drinker
1.050000E-01
Normal-vs-Occasional Drinker
5.985400E-04
Normal-vs-Social Drinker
8.343100E-03
Non Drinker-vs-Daily Drinker
4.264100E-02
Non Drinker-vs-Weekly Drinker
4.634400E-01
Non Drinker-vs-Occasional Drinker
6.350200E-02
Non Drinker-vs-Social Drinker
9.777000E-01
Daily Drinker-vs-Weekly Drinker
2.258300E-02
Daily Drinker-vs-Occasional Drinker
9.592400E-01
Daily Drinker-vs-Social Drinker
5.077900E-02
Weekly Drinker-vs-Occasional Drinker
3.399900E-02
Weekly Drinker-vs-Social Drinker
5.155600E-01
Occasional Drinker-vs-Social Drinker
6.593800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.057000E-01
Normal-vs-Grade 2
8.733000E-01
Normal-vs-Grade 3
8.863000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.762200E-01
Grade 1-vs-Grade 3
2.049600E-01
Grade 1-vs-Grade 4
8.057000E-01
Grade 2-vs-Grade 3
7.664200E-01
Grade 2-vs-Grade 4
8.733000E-01
Grade 3-vs-Grade 4
8.863000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.193000E-04
Normal-vs-NonDiabetic
3.462000E-03
Diabetic-vs-NonDiabetic
1.418620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.175840E-02
Normal-vs-NoPancreatitis
2.017500E-03
Pancreatitis-vs-NoPancreatitis
4.715000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.163900E-04
Normal-vs-N1
3.341500E-03
N0-vs-N1
1.983790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.996270E-03
Normal-vs-TP53-NonMutant
7.336900E-03
TP53-Mutant-vs-TP53-NonMutant
4.903600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
